FDC Limited has informed the Exchange regarding a press release dated October 29, 2020, titled "Launch of stronger versions of Favipiravir Drug (PiFLU and Favenza) meant to treat mild to moderate cases of Covid 19.".
Press Release Oct 30 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from FDC
Later from FDC
- Press Release Nov 11 2020
- Press Release Feb 06 2021
- Press Release May 27 2021
- Press Release Jul 12 2021
- Press Release Aug 13 2021
Follow FDC into a list and get an email when it puts out news.
Follow FDC